Workflow
高性能线束装备
icon
Search documents
海昌智能IPO:子公司亏损拖累业绩 跨区经营隐忧凸显
Xi Niu Cai Jing· 2025-07-03 03:17
Core Viewpoint - HeBi HaiChang Intelligent Technology Co., Ltd. has received approval for its IPO application from the Beijing Stock Exchange, with Guojin Securities as the sponsor [2][4]. Company Overview - HeBi HaiChang focuses on the research, development, production, and sales of high-performance wiring harness equipment, providing intelligent solutions and related services for the downstream wiring harness manufacturing industry [2][4]. - The company's products serve various industries that utilize wiring harnesses, including automotive, information communication, and photovoltaic energy storage [2]. Financial Performance - The revenue for HeBi HaiChang from 2022 to 2024 is projected to be 520 million yuan, 652 million yuan, and 800 million yuan, respectively [4]. - The net profit for the same period is expected to be 108 million yuan, 121 million yuan, and 115 million yuan, indicating a year-on-year decline of 4.96% in 2024 [4]. - The decline in profitability is linked to losses from its core subsidiary, Kunshan Haihong, which reported a net loss of 10.59 million yuan in 2024 and a negative net asset of 20.32 million yuan [4]. Asset Impairment - HeBi HaiChang has experienced increasing asset impairment losses from 3.11 million yuan in 2022 to 13.13 million yuan in 2024 [5]. - The rising impairment losses are attributed to the inefficiencies in production at Kunshan Haihong, which was established to expand into the East China market but has faced challenges in meeting customer demands [5].
海昌智能年入8亿元冲击北交所IPO,曾因关联交易未准确披露收警示函
Sou Hu Cai Jing· 2025-06-30 01:09
Core Viewpoint - Hebi Haichang Intelligent Technology Co., Ltd. (referred to as "Haichang Intelligent") has submitted its IPO application to the Beijing Stock Exchange, focusing on high-performance wiring harness equipment and intelligent solutions for various industries, including automotive, information communication, and photovoltaic energy storage [1][2]. Financial Summary - As of December 31, 2024, total assets are projected to be approximately CNY 989.91 million, an increase from CNY 793.70 million in 2023 and CNY 743.53 million in 2022 [3]. - Total equity is expected to reach CNY 509.85 million by the end of 2024, up from CNY 394.40 million in 2023 and CNY 273.30 million in 2022 [3]. - Revenue for the years 2022, 2023, and 2024 is reported as CNY 520.30 million, CNY 652.28 million, and CNY 799.64 million respectively, indicating a growth trend [3]. - The net profit for the same years is CNY 107.64 million, CNY 121.09 million, and CNY 114.76 million, showing fluctuations in profitability [3]. - The gross profit margin has decreased from 37.74% in 2022 to 34.21% in 2024 [3]. - The company’s R&D expenditure as a percentage of revenue is projected to be 7.40% in 2024, compared to 8.21% in 2023 and 6.13% in 2022 [3]. Ownership and Control - Hebi Jurin holds 22.30% of the shares and indirectly controls 13.41% of the voting rights, totaling 35.71% of the voting rights, making it the controlling shareholder [5]. - The actual controllers of the company include seven individuals, with Yang Yongjun serving as the chairman [5][6]. - The seven individuals collectively hold 90.83% of Hebi Jurin's equity, which allows them to exercise significant control over the company's decision-making processes [5]. Regulatory Compliance - Haichang Intelligent faced regulatory actions due to inaccurate disclosures regarding its relationship with Henan Tuoshuo Industrial Co., Ltd., resulting in warning letters from the China Securities Regulatory Commission [8].
海昌智能从天海电子剥离5年后冲刺IPO,7人共同实控人团合计控股41%
Sou Hu Cai Jing· 2025-06-27 01:38
Core Viewpoint - Hebi Haichang Intelligent Technology Co., Ltd. (referred to as "Haichang Intelligent") has received acceptance for its IPO application on the Beijing Stock Exchange, indicating a significant step towards public listing and capital raising [1][2]. Company Overview - Haichang Intelligent is a high-tech enterprise primarily engaged in the research, development, production, and sales of high-performance wiring harness equipment, providing intelligent solutions and related services to the downstream wiring harness manufacturing industry [2]. - The company serves various industries that utilize wiring harnesses, including automotive, information communication, and photovoltaic energy storage [2]. - Haichang Intelligent has established long-term stable partnerships with numerous well-known domestic and international companies, including Tianhai Electronics, Aptiv, BYD, Luxshare Precision, Leoni, Lear, and Great Wall Motors [2]. Financial Performance - The company's total assets are projected to reach approximately CNY 989.91 million by December 31, 2024, up from CNY 793.70 million in 2023 and CNY 743.53 million in 2022 [3]. - Shareholder equity is expected to increase to CNY 509.85 million in 2024, compared to CNY 394.40 million in 2023 and CNY 273.30 million in 2022 [3]. - Revenue for the years 2022, 2023, and 2024 is reported as CNY 520.30 million, CNY 652.28 million, and CNY 799.64 million, respectively, indicating a growth trend [3]. - The net profit for the same years is CNY 107.64 million, CNY 121.09 million, and CNY 114.76 million, showing fluctuations in profitability [3]. - The gross profit margin has slightly decreased from 37.74% in 2022 to 34.21% in 2024 [3]. Major Clients - Tianhai Electronics is the largest customer of Haichang Intelligent, with sales amounts of CNY 190.88 million, CNY 169.43 million, and CNY 198.29 million for the years 2022, 2023, and 2024, respectively, accounting for 36.69%, 25.98%, and 24.80% of total revenue [9]. - Other significant clients include BYD, Luxshare Precision, and Aptiv, contributing to a diversified customer base [9]. Shareholding Structure - As of the signing date of the prospectus, Hebi Jurin holds 22.30% of the shares and indirectly controls 35.71% of the voting rights of the company [6]. - The actual controllers of the company include seven individuals who collectively hold 90.83% of Hebi Jurin's shares, thereby exercising significant control over the company's decision-making processes [6][7].
又新受理19家IPO!今年至今获受理共80家
梧桐树下V· 2025-06-25 11:15
Group 1 - A total of 19 IPOs were accepted by Shenzhen and Beijing Stock Exchanges from June 23 to June 24, including 1 from Shenzhen Main Board, 4 from Shenzhen ChiNext, and 14 from Beijing Stock Exchange [1] - As of June 24, 2025, a total of 80 IPO projects have been accepted across the three major exchanges, with 14 from Shanghai, 17 from Shenzhen, and 49 from Beijing [2] Group 2 - Hangzhou Fu'en Co., Ltd. was accepted for IPO on Shenzhen Main Board on June 24, with a registered capital of 175 million yuan [3] - The company focuses on sustainable development and is a global supplier of eco-friendly fabrics, primarily producing recycled fabrics [4] - The controlling shareholder is Paiya Holdings, holding 36.57% of shares, with actual controllers being Wang Neili, Wang Xuelin, and Wang Enwei, collectively controlling 83.89% of voting rights [5] - The company reported revenues of 1.76 billion yuan in 2022, 1.52 billion yuan in 2023, and projected 1.81 billion yuan in 2024, with net profits of 276 million yuan, 227 million yuan, and 254 million yuan respectively [6][7] - The company meets the listing criteria of Shenzhen Stock Exchange, with positive net profits over the last three years and a cumulative net profit of no less than 200 million yuan [8] Group 3 - Suzhou Betterly Polymer Materials Co., Ltd. was accepted for IPO on ChiNext on June 24, with a registered capital of 197 million yuan [13] - The company specializes in the R&D, production, and sales of electronic materials and new chemical materials, with applications in photovoltaic, 3C electronics, and new energy vehicles [14] - The controlling shareholder is Wang Quan, holding 37.26% of shares, with actual control by Wang Quan and Ouyang Xufeng [15] - The company reported revenues of 635 million yuan in 2022, 2.27 billion yuan in 2023, and projected 2.52 billion yuan in 2024, with net profits of 13 million yuan, 84 million yuan, and 95 million yuan respectively [16][17] - The company meets the listing criteria of ChiNext, with positive net profits over the last two years and a cumulative net profit of no less than 100 million yuan [19] Group 4 - Nantong Lianya Pharmaceutical Co., Ltd. was accepted for IPO on ChiNext on June 24, with a registered capital of 757.86 million yuan [24] - The company is a R&D-driven high-tech enterprise focusing on complex drug formulations, primarily producing high-end generic drugs [26] - The controlling shareholder is Lianya Cayman, holding 22.62% of shares, with actual controllers being Zhang Guohua and others [27] - The company reported revenues of 550 million yuan in 2022, 700 million yuan in 2023, and projected 866 million yuan in 2024, with net profits of 68 million yuan, 87 million yuan, and 181 million yuan respectively [28][29] - The company meets the listing criteria with positive net profits over the last two years and a cumulative net profit of no less than 100 million yuan [30] Group 5 - Guizhou Southern Dairy Co., Ltd. was accepted for IPO on Beijing Stock Exchange on June 24, with a registered capital of 150 million yuan [35] - The company is engaged in the manufacturing and sales of dairy products and related beverages, including various low-temperature and room-temperature dairy products [36] - The controlling shareholder is Guiyang Agricultural Investment Group, holding 51.01% of shares, with significant influence from the Guiyang State-owned Assets Supervision and Administration Commission [37] - The company reported revenues of 1.58 billion yuan in 2022, 1.80 billion yuan in 2023, and projected 1.82 billion yuan in 2024, with net profits of 165 million yuan, 199 million yuan, and 207 million yuan respectively [38][39] - The company meets the listing criteria with a market value of no less than 200 million yuan and positive net profits over the last two years [40] Group 6 - Zhongjiankangqiao Pharmaceutical Group Co., Ltd. was accepted for IPO on Beijing Stock Exchange on June 24, with a registered capital of 75.40 million yuan [45] - The company focuses on chronic disease medications, particularly for cardiovascular diseases, and has established a comprehensive industry chain [46] - The controlling shareholder is Furong Kangda, holding 57.58% of shares, with actual controllers being Liu Zongjie and others [47] - The company reported revenues of 267 million yuan in 2022, 343 million yuan in 2023, and projected 446 million yuan in 2024, with net profits of 61 million yuan, 111 million yuan, and 103 million yuan respectively [48][49] - The company meets the listing criteria with a market value of no less than 200 million yuan and positive net profits over the last two years [51] Group 7 - Beijing Kangmite Technology Co., Ltd. was accepted for IPO on Beijing Stock Exchange on June 24, with a registered capital of 120.20 million yuan [56] - The company specializes in the R&D, production, and sales of electronic packaging materials and high-performance modified plastics [57]